Oxford Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Oxford Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-191,847	Closed	-$505K	–	1379
2019 Q4	$505K	Sell	191,847 -57,070	-23%	-$170K	0.01%	1230
2019 Q3	$896K	Sell	248,917 -9,488	-4%	-$33.6K	0.02%	994
2019 Q2	$871K	Buy	258,405 +81,089	+46%	+$286K	0.02%	1040
2019 Q1	$484K	Buy	177,316 +35,538	+25%	+$116K	0.01%	1229
2018 Q4	$394K	Buy	141,778 +67,574	+91%	+$221K	0.01%	1292
2018 Q3	$300K	Sell	74,204 -92,275	-55%	-$419K	0.01%	1494
2018 Q2	$853K	Sell	166,479 -63,462	-28%	-$387K	0.02%	1123
2018 Q1	$1.26M	Buy	229,941 +33,474	+17%	+$236K	0.03%	823
2017 Q4	$1.61M	Sell	196,467 -33,992	-15%	-$325K	0.03%	695
2017 Q3	$2.42M	Sell	230,459 -47,293	-17%	-$525K	0.05%	527
2017 Q2	$3.07M	Buy	277,752 +2,563	+0.9%	+$23.9K	0.06%	396
2017 Q1	$2.3M	Sell	275,189 -3,849	-1%	-$27.1K	0.06%	414
2016 Q4	$1.94M	Buy	279,038 +80,515	+41%	+$514K	0.07%	333
2016 Q3	$1.01M	Sell	198,523 -116,304	-37%	-$695K	0.03%	517
2016 Q2	$1.88M	Buy	314,827 +159,834	+103%	+$887K	0.06%	379
2016 Q1	$705K	Buy	154,993 +84,519	+120%	+$376K	0.02%	551
2015 Q4	$319K	Buy	+70,474	New	+$298K	0.01%	746

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's ENZ Position: Q1 2020 in Review

Oxford Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2020, closing a stake of 191,847 shares — an estimated $505K sold.

Oxford Asset Management first reported a position in ENZ in Q4 2015 and held it in 17 quarters. The position peaked at $3.07M in Q2 2017. 76 funds tracked by Wall St. Rank hold ENZ as of Q1 2020.

Oxford Asset Management reported no remaining Enzo Biochem, Inc. position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 191,847 Enzo Biochem, Inc. shares in Q1 2020, an estimated $505K.
Oxford Asset Management first reported a position in Enzo Biochem, Inc. in Q4 2015 and held it in 17 quarters.
Oxford Asset Management's Enzo Biochem, Inc. position peaked at $3.07M in Q2 2017.
76 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.